194 related articles for article (PubMed ID: 7045153)
1. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.
Best JD; Judzewitsch RG; Pfeifer MA; Beard JC; Halter JB; Porte D
Diabetes; 1982 Apr; 31(4 Pt 1):333-8. PubMed ID: 6759249
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
[TBL] [Abstract][Full Text] [Related]
4. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
[TBL] [Abstract][Full Text] [Related]
5. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
Turner RC; Holman RR
Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
Ahrén B; Larsson H; Holst JJ
J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
[TBL] [Abstract][Full Text] [Related]
7. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes.
McCulloch DK; Raghu PK; Johnston C; Klaff LJ; Kahn SE; Beard JC; Ward WK; Benson EA; Koerker DJ; Bergman RN
J Clin Endocrinol Metab; 1988 Oct; 67(4):785-92. PubMed ID: 3047163
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
9. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
11. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
[TBL] [Abstract][Full Text] [Related]
12. Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs.
Ward WK; Wallum BJ; Beard JC; Taborsky GJ; Porte D
Diabetes; 1988 Jun; 37(6):723-9. PubMed ID: 3289992
[TBL] [Abstract][Full Text] [Related]
13. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
Barnes AJ; Garbien KJ; Crowley MF; Bloom A
Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
[No Abstract] [Full Text] [Related]
14. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
Chu PC; Conway MJ; Krouse HA; Goodner CJ
Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
[No Abstract] [Full Text] [Related]
15. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
Hollander PM; Asplin CM; Palmer JP
Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
[TBL] [Abstract][Full Text] [Related]
16. The effect of chlorpropamide therapy upon glucose-insulin relationships in adult diabetics.
Goodner CJ; Chu PC; Conway MJ; Werrbach JH
Adv Metab Disord; 1970; 1():Suppl 1:431+. PubMed ID: 4911190
[No Abstract] [Full Text] [Related]
17. Relationship of islet function to insulin action in human obesity.
Beard JC; Ward WK; Halter JB; Wallum BJ; Porte D
J Clin Endocrinol Metab; 1987 Jul; 65(1):59-64. PubMed ID: 3294880
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of B and A cell function during prolonged glucose infusion in human subjects.
Ward WK; Halter JB; Beard JC; Porte D
Am J Physiol; 1984 May; 246(5 Pt 1):E405-11. PubMed ID: 6372519
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus.
Broadstone VL; Pfeifer MA; Bajaj V; Stagner JI; Samols E
Diabetes; 1987 Aug; 36(8):932-7. PubMed ID: 2885238
[TBL] [Abstract][Full Text] [Related]
20. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.
Henry RR; Scheaffer L; Olefsky JM
J Clin Endocrinol Metab; 1985 Nov; 61(5):917-25. PubMed ID: 4044780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
